Welcome to our dedicated page for Veradigm SEC filings (Ticker: MDRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Veradigm Inc. SEC filings document the company’s healthcare technology business, OTC-traded common stock and formal disclosures around financial reporting, governance and capital structure. Recent filings include Current Reports on Form 8-K covering leadership appointments, preliminary financial information, material agreements and amendments to the company’s stockholder rights plan.
The filing record also includes late-filing notices for annual reports, disclosures about financial reporting and internal-control matters, board-observer and stockholder-agreement arrangements, and the conclusion of an SEC investigation without a recommended enforcement action. These filings record Veradigm’s public-company status, common stock trading symbol MDRX, rights-plan mechanics and governance changes while the company works through delayed periodic reporting.
Veradigm Inc. (MDRX) has a new significant shareholder group led by Madison Avenue International LP. As of January 29, 2026, the group reports beneficial ownership of 7,167,999 shares of common stock, equal to about 6.6% of Veradigm’s outstanding shares.
The ownership percentage is calculated using 108,900,000 shares outstanding as of September 29, 2025, as cited from a prior company press release. The filing is made jointly by several related investment entities and Eli Samaha, who may be deemed to share voting and dispositive power. They certify the holdings are not for the purpose of changing or influencing control of Veradigm, other than activities solely in connection with a director nomination process.
Mason Capital Management LLC and its principals have disclosed a significant passive stake in Veradigm Inc. They report beneficial ownership of 6,283,161 shares of Veradigm common stock, representing 5.8% of the outstanding shares, as of an event dated 01/22/2026.
The ownership is held through Mason Capital Master Fund, L.P., over which Mason Capital Management has voting and investment discretion. Managing principals Kenneth M. Garschina and Michael E. Martino are reported as sharing voting and dispositive power over the same shares. The percentage is based on 108,900,000 Veradigm shares outstanding as of September 29, 2025.
The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Veradigm, consistent with a passive investment reported on Schedule 13G.
Veradigm Inc. reported that it has further amended its Stockholder Agreement with Charles Myers and Jessica Myers. Myers currently serves as an observer to Veradigm’s board of directors. On January 15, 2026, the company signed a Second Amendment that extends the agreement’s Termination Date to July 26, 2026, reflecting the value the company believes Myers has contributed in this observer role.
The amendment also allows Veradigm and the Myers Parties, by mutual consent, to extend the Termination Date again to January 26, 2027. This filing focuses on governance and board‑level engagement rather than financial results.